Pattarawat P - Search Results

1

An ex vivo ovulation system enables the discovery of novel ovulatory pathways and nonhormonal contraceptive candidates†.

Zhang J, Goods BA, Pattarawat P, Wang Y, Haining T, Zhang Q, Shalek AK, Duncan FE, Woodruff TK, Xiao S. Zhang J, et al. Among authors: pattarawat p. Biol Reprod. 2023 Apr 11;108(4):629-644. doi: 10.1093/biolre/ioad009. Biol Reprod. 2023. PMID: 36708230 Free PMC article.

2

Vitrification preserves murine ovarian follicular cell transcriptome in a 3D encapsulated in vitro follicle growth system.

Wang Y, Drake RS, Russo DD, Pattarawat P, Zhang Q, Zelinski MB, Shalek AK, Goods BA, Xiao S. Wang Y, et al. Among authors: pattarawat p. Biol Reprod. 2021 Dec 20;105(6):1378-1380. doi: 10.1093/biolre/ioab185. Biol Reprod. 2021. PMID: 34591115 Free PMC article. No abstract available.

3

Effects of Cyanobacterial Harmful Algal Bloom Toxin Microcystin-LR on Gonadotropin-Dependent Ovarian Follicle Maturation and Ovulation in Mice.

Wang Y, Pattarawat P, Zhang J, Kim E, Zhang D, Fang M, Jannaman EA, Yuan Y, Chatterjee S, Kim JJ, Scott GI, Zhang Q, Xiao S. Wang Y, et al. Among authors: pattarawat p. Environ Health Perspect. 2023 Jun;131(6):67010. doi: 10.1289/EHP12034. Epub 2023 Jun 21. Environ Health Perspect. 2023. PMID: 37342990 Free PMC article.

4

A new tissue-agnostic microfluidic device to model physiology and disease: the lattice platform.

Campo H, Zha D, Pattarawat P, Colina J, Zhang D, Murphy A, Yoon J, Russo A, Rogers HB, Lee HC, Zhang J, Trotter K, Wagner S, Ingram A, Pavone ME, Dunne SF, Boots CE, Urbanek M, Xiao S, Burdette JE, Woodruff TK, Kim JJ. Campo H, et al. Among authors: pattarawat p. Lab Chip. 2023 Nov 7;23(22):4821-4833. doi: 10.1039/d3lc00378g. Lab Chip. 2023. PMID: 37846545

5

A triple combination gemcitabine + romidepsin + cisplatin to effectively control triple-negative breast cancer tumor development, recurrence, and metastasis.

Pattarawat P, Hunt JT, Poloway J, Archibald CJ, Wang HR. Pattarawat P, et al. Cancer Chemother Pharmacol. 2021 Sep;88(3):415-425. doi: 10.1007/s00280-021-04298-y. Epub 2021 May 27. Cancer Chemother Pharmacol. 2021. PMID: 34043046 Free PMC article.

6

Compensatory combination of romidepsin with gemcitabine and cisplatin to effectively and safely control urothelial carcinoma.

Pattarawat P, Hong T, Wallace S, Hu Y, Donnell R, Wang TH, Tsai CL, Wang J, Wang HR. Pattarawat P, et al. Br J Cancer. 2020 Jul;123(2):226-239. doi: 10.1038/s41416-020-0877-8. Epub 2020 May 11. Br J Cancer. 2020. PMID: 32390005 Free PMC article.

7

Formulation of a triple combination gemcitabine plus romidepsin + cisplatin regimen to efficaciously and safely control triple-negative breast cancer tumor development.

Pattarawat P, Wallace S, Pfisterer B, Odoi A, Wang HR. Pattarawat P, et al. Cancer Chemother Pharmacol. 2020 Jan;85(1):141-152. doi: 10.1007/s00280-019-04013-y. Epub 2019 Dec 21. Cancer Chemother Pharmacol. 2020. PMID: 31865420

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7 results

Search Page